Pituitary

Papers
(The H4-Index of Pituitary is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey186
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas64
The impact of facility type and volume on treatment and overall survival in craniopharyngioma59
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland46
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies42
Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 202240
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours40
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study36
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency35
Increased impulsivity and higher odds of compulsive shopping among cabergoline-treated patients with prolactinoma: a case-control study27
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life25
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients22
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening22
Pituitary: hic manebimus optime21
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly21
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery20
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience19
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy19
0.10763096809387